Credit Suisse’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $35K | Buy |
|
|||||
|
2017
Q4 | $153K | Sell |
|
|||||
|
2017
Q3 | $515K | Buy |
|
|||||
|
2017
Q2 | $680K | Sell |
|
|||||
|
2017
Q1 | $808K | Sell |
|
|||||
|
2016
Q4 | $449K | Sell |
|
|||||
|
2016
Q3 | $877K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.47M | Buy |
|
|||||
|
2015
Q4 | $4.26M | Sell |
|
|||||
|
2015
Q3 | $8.03M | Sell |
|
|||||
|
2015
Q2 | $19.9M | Buy |
|
|||||
|
2015
Q1 | $7.69M | Buy |
|
|||||
|
2014
Q4 | $3.42M | Sell |
|
|||||
|
2014
Q3 | $5.33M | Buy |
|
|||||
|
2014
Q2 | $4.42M | Buy |
|
|||||
|
2014
Q1 | $1.82M | Sell |
|
|||||
|
2013
Q4 | $2.06M | Buy |
|
|||||
|
2013
Q3 | $703K | Buy |
|
|||||
|
2013
Q2 | $422K | Buy |
|